X

Name: ADVIL LIQUI-GELS
Brand: ADVIL LIQUI-GELS
Price: 13.24 USD
Availability: InStock
Rating: 4.0 (3 reviews)

What is metabolic syndrome?

Metabolic syndrome is the name for a group of risk factors for heart disease, diabetes, and other health problems. You can have just one risk factor, but people often have several of them together. When you have at least three of them, it is called metabolic syndrome. These risk factors include:

A large waistline, also called abdominal obesity or "having an apple shape." Too much fat around the stomach is a greater risk factor for heart disease than too much fat in other parts of the body.
Having a high triglyceride level. Triglycerides are a type of fat found in the blood.
Having a low HDL cholesterol level. HDL is sometimes called the "good" cholesterol because it helps remove cholesterol from your arteries.
Having high blood pressure. If your blood pressure stays high over time, it can damage your heart and lead to other health problems.
Having a high fasting blood sugar. Mildly high blood sugar may be an early sign of diabetes.

The more factors you have, the higher your risk for heart disease, diabetes, and stroke is.

What causes metabolic syndrome?

Metabolic syndrome has several causes that act together:

Overweight and obesity
An inactive lifestyle
Insulin resistance, a condition in which the body can't use insulin properly. Insulin is a hormone that helps move blood sugar into your cells to give them energy. Insulin resistance can lead to high blood sugar levels.
Age - your risk goes up as get older
Genetics - ethnicity and family history

People who have metabolic syndrome often also have excessive blood clotting and inflammation throughout the body. Researchers don't know whether these conditions cause metabolic syndrome or worsen it.

Who is at risk for metabolic syndrome?

The most important risk factors for metabolic syndrome are:

Abdominal obesity (a large waistline)
An inactive lifestyle
Insulin resistance

There are certain groups of people who have an increased risk of metabolic syndrome:

Some racial and ethnic groups. Mexican Americans have the highest rate of metabolic syndrome, followed by White and Black people.
People who have diabetes
People who have a sibling or parent who has diabetes
Women with polycystic ovary syndrome (PCOS)
People who take medicines that cause weight gain or changes in blood pressure, blood cholesterol, and blood sugar levels

What are the symptoms of metabolic syndrome?

Most of the metabolic risk factors have no obvious signs or symptoms, except for a large waistline.

How is metabolic syndrome diagnosed?

Your health care provider will diagnose metabolic syndrome based on the results of a physical exam and blood tests. You must have at least three of the risk factors to be diagnosed with metabolic syndrome:

A large waistline, which means a waist measurement of
- 35 inches or more for women
- 40 inches or more for men
A high triglyceride level, which is 150 mg/dL or higher
A low HDL cholesterol level, which is
- Less than 50 mg/dL for women
- Less than 40 mg/dL for men
High blood pressure, which is a reading of 130/85 mmHg or higher.
A high fasting blood sugar, which is 100 mg/dL or higher

What are the treatments for metabolic syndrome?

The most important treatment for metabolic syndrome is a heart-healthy lifestyle, which includes:

A heart-healthy eating plan, which limits the amount of saturated and trans fats that you eat. It encourages you to choose a variety of nutritious foods, including fruits, vegetables, whole grains, and lean meats.
Aiming for a healthy weight
Managing stress
Getting regular physical activity
Quitting smoking (or not starting if you don't already smoke)

If making lifestyle changes is not enough, you may need to take medicines. For example, you may need medicines to lower cholesterol or blood pressure.

Can metabolic syndrome be prevented?

The best way to prevent metabolic syndrome is through the heart-healthy lifestyle changes.

NIH: National Heart, Lung, and Blood Institute

X FDA Approved Drugs

8-MOP [Methoxsalen^{C₁₂H₈O₄}]

10mg (oral capsule)

Valeant Pharm Intl^{Approved Prior To Jan 1, 1982}

ABILIFY [Aripiprazole^{C₂₃H₂₇Cl₂N₃O₂}]

10mg (oral tablet)

15mg (oral tablet)

20mg (oral tablet)

2mg (oral tablet)

30mg (oral tablet)

Otsuka^{Nov 15, 2002}

Acute treatment of manic and mixed episodes associated with bipolar i disorder.
Adjunctive treatment of major depressive disorder (mdd).
Treatment of irritability associated with autistic disorder.
Treatment of major depressive disorder (mdd).
Treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar i disorder, adjunctive treatment of major depressive disorder, and treatment of irritability associated with autistic disorder.
Treatment of schizophrenia.

ABILIFY MAINTENA KIT [Aripiprazole^{C₂₃H₂₇Cl₂N₃O₂}]

300mg (intramuscular for suspension, extended release)

300mg/vial (intramuscular for suspension, extended release)

400mg (intramuscular for suspension, extended release)

400mg/vial (intramuscular for suspension, extended release)

Otsuka Pharm Co Ltd^{Sep 29, 2014}

Treatment of schizophrenia, with efficacy in treating acute episodes of schizophrenia.
Treatment of schizophrenia.
Use of aripiprazole in extended release injectable suspension in treating acute episodes of schizophrenia.
Use of aripiprazole in extended release injectable suspension.

ABRAXANE [Paclitaxel^{C₄₇H₅₁NO₁₄}]

100mg/vial (iv (infusion) for suspension)

Abraxis Bioscience^{Jan 7, 2005}

Treatment of breast cancer.
Treatment of lung cancer.
Treatment of pancreatic cancer.

ACANYA [Benzoyl Peroxide^{C₁₄H₁₀O₄} : Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

2.5% : eq 1.2% base (topical gel)

Dow Pharm^{Oct 23, 2008}

Topical treatment of acne vulgaris in patients 12 years or older.
Topical treatment of acne vulgaris.
Treatment of acne vulgaris.
Treatment of acne.

ACCUNEB [Albuterol Sulfate^{2C₁₃H₂₁NO₃H₂O₄S}]

eq 0.021% base (inhalation solution)

eq 0.042% base (inhalation solution)

Mylan Speciality Lp^{Apr 30, 2001}

Indicated for the relief of bronchospasm in patients 2-12 years of age with asthma (reversible obstructive airway disease).

ACETAMINOPHEN AND CODEINE PHOSPHATE [Acetaminophen^{C₈H₉NO₂} : Codeine Phosphate^{2C₁₈H₂₁NO₃H₂O2H₃O₄P}]

120mg/5ml : 12mg/5ml (oral solution)

300mg : 15mg (oral tablet)

300mg : 30mg (oral tablet)

300mg : 60mg (oral tablet)

Hi Tech Pharma^{Apr 26, 1996}
Mikart^{Oct 27, 1992}
Pharm Assoc^{Approved Prior To Jan 1, 1982}
Vintage Pharms^{Nov 10, 2011}
Wockhardt^{Approved Prior To Jan 1, 1982}
Aurolife Pharma Llc^{Apr 15, 2013}
Mallinckrodt Inc^{May 31, 2001}
Teva^{Mar 6, 1985}
Amneal Pharms Ny^{May 29, 2008}
Sun Pharm Inds Ltd^{Approved Prior To Jan 1, 1982}

ACETAMINOPHEN, ASPIRIN AND CAFFEINE [Acetaminophen^{C₈H₉NO₂} : Aspirin^C₉H₈O₄ : Caffeine^{C₈H₁₀N₄O₂}]

OTC

250mg : 250mg : 65mg (oral tablet)

Perrigo^{Nov 26, 2001}

ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE [Acetaminophen^{C₈H₉NO₂} : Caffeine^{C₈H₁₀N₄O₂} : Dihydrocodeine Bitartrate^{C₁₈H₂₃NO₃C₄H₆O₆}]

325mg : 30mg : 16mg (oral tablet)

Larken Labs Inc^{Sep 30, 2016}

ACETASOL HC [Acetic Acid, Glacial : Hydrocortisone^{C₂₁H₃₀O₅}]

2% : 1% (otic solution/drops)

Actavis Mid Atlantic^{Jan 13, 1982}

ACETAZOLAMIDE [Acetazolamide^{C₄H₆N₄O₃S₂}]

125mg (oral tablet)

250mg (oral tablet)

500mg (oral capsule, extended release)

Heritage Pharma^{Oct 27, 2016}
Mutual Pharm^{Jun 22, 1988}
Taro^{May 28, 1997}
Lannett^{Approved Prior To Jan 1, 1982}
Heritage Pharms Inc^{Jul 14, 2011}
Nostrum Labs Inc^{Mar 29, 2016}
Novast Labs Ltd^{Sep 30, 2016}
Zydus Pharms Usa Inc^{Dec 10, 2008}

ACETAZOLAMIDE SODIUM [Acetazolamide Sodium^{C₄H₅N₄O₃S₂Na}]

eq 500mg base/vial (injection injectable)

Emcure Pharms Ltd^{Dec 19, 2014}
Par Sterile Products^{Jun 20, 2017}
Sagent Agila^{May 9, 2012}
West-ward Pharms Int^{Feb 28, 1995}
X Gen Pharms^{Dec 10, 2008}

ACETIC ACID [Acetic Acid, Glacial]

2% (otic solution/drops)

Taro^{Sep 6, 1984}
Vintage^{Feb 24, 2005}
Wockhardt^{Jul 26, 1996}

ACETIC ACID 0.25% IN PLASTIC CONTAINER [Acetic Acid, Glacial]

250mg/100ml (irrigation, urethral solution)

B Braun^{Approved Prior To Jan 1, 1982}
Baxter Hlthcare^{Feb 19, 1982}
Icu Medical Inc^{Approved Prior To Jan 1, 1982}

ACIPHEX [Rabeprazole Sodium^{C₁₈H₂₀N₃O₃SNa}]

20mg (oral tablet, delayed release)

Eisai Inc^{Aug 19, 1999}

ACIPHEX SPRINKLE [Rabeprazole Sodium^{C₁₈H₂₀N₃O₃SNa}]

10mg (oral capsule, delayed release)

5mg (oral capsule, delayed release)

Fsc Therap^{Mar 26, 2013}

ACTICLATE [Doxycycline Hyclate^{2C₂₂H₂₄N₂O₈C₂H₆O2ClHH₂O}]

eq 150mg base (oral tablet)

eq 75mg base (oral tablet)

Aqua Pharms Llc^{Jul 25, 2014}

ACTICLATE CAP [Doxycycline Hyclate^{2C₂₂H₂₄N₂O₈C₂H₆O2ClHH₂O}]

eq 75mg base (oral capsule)

Aqua Pharms^{Apr 26, 2016}

ACTOPLUS MET [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

500mg : eq 15mg base (oral tablet)

850mg : eq 15mg base (oral tablet)

Takeda Pharms Usa^{Aug 29, 2005}

ACTOPLUS MET XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

1gm : eq 15mg base (oral tablet, extended release)

1gm : eq 30mg base (oral tablet, extended release)

Takeda Pharms Usa^{May 12, 2009}

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with pioglitazone and metformin or who have inadequate glycemic control on pioglitazone or metformin alone.
Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with a pioglitazone and metformin.
To reduce gastrointestinal side effects administer with a meal; as starting dose administer once daily with evening meal.

ACULAR [Ketorolac Tromethamine^{C₁₅H₁₃NO₃C₄H₁₁NO₃}]

0.5% (ophthalmic solution/drops)

Allergan^{Nov 9, 1992}

ACULAR LS [Ketorolac Tromethamine^{C₁₅H₁₃NO₃C₄H₁₁NO₃}]

0.4% (ophthalmic solution/drops)

Allergan^{May 30, 2003}

A method of controlling postoperative ocular pain and burning/stinging in a patient.
A method of treating ocular pain and/or enhancing ocular comfort.
A method of treating ocular pain.
A method of treating or preventing ocular pain and burning.
A method of treating or preventing ocular pain and burning/stinging following corneal surgery.
A method of treating or preventing ocular pain in a patient.
A method of treating or reducing ocular pain and burning/stinging.

ACUVAIL [Ketorolac Tromethamine^{C₁₅H₁₃NO₃C₄H₁₁NO₃}]

0.45% (ophthalmic solution/drops)

Allergan^{Jul 22, 2009}

ACYCLOVIR [Acyclovir^{C₈H₁₁N₅O₃}]

200mg (oral capsule)

200mg/5ml (oral suspension)

400mg (oral tablet)

5% (topical ointment)

800mg (oral tablet)

Apotex Inc^{Sep 28, 2005}
Boscogen^{Jan 26, 1999}
Cadila Pharms Ltd^{Mar 6, 2014}
Dava Pharms Inc^{Apr 22, 1997}
Teva^{Apr 22, 1997}
Zydus Pharms Usa Inc^{Mar 25, 2016}
Actavis Mid Atlantic^{Apr 28, 1997}
Hi Tech Pharma^{Jun 7, 2005}
Carlsbad^{Apr 30, 1999}
Heritage Pharms Inc^{Oct 31, 1997}
Hetero Labs Ltd V^{Oct 29, 2013}
Mylan Pharms Inc^{Sep 28, 1998}
Amneal Pharms^{Jun 18, 2014}
Fougera Pharms Inc^{May 11, 2016}
Taro^{Dec 21, 2016}

ACYCLOVIR SODIUM [Acyclovir Sodium^{C₈H₁₀N₅O₃Na}]

eq 1gm base/vial (injection injectable)

eq 500mg base/vial (injection injectable)

eq 50mg base/ml (injection injectable)

Hikma Pharms Llc^{Feb 29, 2016}
Mylan Labs Ltd^{Mar 29, 2017}
Zydus Pharms Usa Inc^{Jun 13, 2017}
Fresenius Kabi Usa^{Apr 30, 1998}
Aurobindo Pharma Ltd^{Oct 11, 2013}

ADALAT CC [Nifedipine^{C₁₇H₁₈N₂O₆}]

30mg (oral tablet, extended release)

60mg (oral tablet, extended release)

90mg (oral tablet, extended release)

Alvogen^{Apr 21, 1993}

ADAPALENE AND BENZOYL PEROXIDE [Adapalene^{C₂₈H₂₈O₃} : Benzoyl Peroxide^{C₁₄H₁₀O₄}]

0.1% : 2.5% (topical gel)

Actavis Mid Atlantic^{Sep 30, 2015}

ADASUVE [Loxapine^{C₁₈H₁₈ClN₃O}]

10mg (inhalation powder)

Alexza Pharms^{Dec 21, 2012}

Adasuve is a typical antipsychotic indicated for the acute treatment of agitation associated with schizophrenia or bipolar i disorder in adults.

ADDERALL XR 10 [Amphetamine Aspartate^{2C₉H₁₃NC₄H₇NO₄} : Amphetamine Sulfate^{2C₉H₁₃NH₂O₄S} : Dextroamphetamine Saccharate^{2C₉H₁₃NC₆H₁₀O₈} : Dextroamphetamine Sulfate^{2C₉H₁₃NH₂O₄S}]

2.5mg : 2.5mg : 2.5mg : 2.5mg (oral capsule, extended release)

Shire^{Oct 11, 2001}

ADDERALL XR 15 [Amphetamine Aspartate^{2C₉H₁₃NC₄H₇NO₄} : Amphetamine Sulfate^{2C₉H₁₃NH₂O₄S} : Dextroamphetamine Saccharate^{2C₉H₁₃NC₆H₁₀O₈} : Dextroamphetamine Sulfate^{2C₉H₁₃NH₂O₄S}]

3.75mg : 3.75mg : 3.75mg : 3.75mg (oral capsule, extended release)

Shire^{May 22, 2002}

ADDERALL XR 20 [Amphetamine Aspartate^{2C₉H₁₃NC₄H₇NO₄} : Amphetamine Sulfate^{2C₉H₁₃NH₂O₄S} : Dextroamphetamine Saccharate^{2C₉H₁₃NC₆H₁₀O₈} : Dextroamphetamine Sulfate^{2C₉H₁₃NH₂O₄S}]

5mg : 5mg : 5mg : 5mg (oral capsule, extended release)

Shire^{Oct 11, 2001}

ADDERALL XR 25 [Amphetamine Aspartate^{2C₉H₁₃NC₄H₇NO₄} : Amphetamine Sulfate^{2C₉H₁₃NH₂O₄S} : Dextroamphetamine Saccharate^{2C₉H₁₃NC₆H₁₀O₈} : Dextroamphetamine Sulfate^{2C₉H₁₃NH₂O₄S}]

6.25mg : 6.25mg : 6.25mg : 6.25mg (oral capsule, extended release)

Shire^{May 22, 2002}

ADDERALL XR 30 [Amphetamine Aspartate^{2C₉H₁₃NC₄H₇NO₄} : Amphetamine Sulfate^{2C₉H₁₃NH₂O₄S} : Dextroamphetamine Saccharate^{2C₉H₁₃NC₆H₁₀O₈} : Dextroamphetamine Sulfate^{2C₉H₁₃NH₂O₄S}]

7.5mg : 7.5mg : 7.5mg : 7.5mg (oral capsule, extended release)

Shire^{Oct 11, 2001}

ADDERALL XR 5 [Amphetamine Aspartate^{2C₉H₁₃NC₄H₇NO₄} : Amphetamine Sulfate^{2C₉H₁₃NH₂O₄S} : Dextroamphetamine Saccharate^{2C₉H₁₃NC₆H₁₀O₈} : Dextroamphetamine Sulfate^{2C₉H₁₃NH₂O₄S}]

1.25mg : 1.25mg : 1.25mg : 1.25mg (oral capsule, extended release)

Shire^{May 22, 2002}

ADDYI [Flibanserin^{C₂₀H₂₁F₃N₄O}]

100mg (oral tablet)

Sprout Pharms^{Aug 18, 2015}

Use of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat hypoactive sexual desire disorder (hsdd).

ADEFOVIR DIPIVOXIL [Adefovir Dipivoxil^{C₂₀H₃₂N₅O₈P}]

10mg (oral tablet)

Sigmapharm Labs Llc^{Aug 29, 2013}

ADIPEX-P [Phentermine Hydrochloride^{C₁₀H₁₅NClH}]

37.5mg (oral tablet)

Teva^{Approved Prior To Jan 1, 1982}

ADLYXIN [Lixisenatide]

0.15mg/3ml (0.05mg/ml) (subcutaneous solution)

0.3mg/3ml (0.1mg/ml) (subcutaneous solution)

Sanofi-aventis Us^{Jul 27, 2016}

Combination treatment with a glitazone for improvement of glycemic control in type 2 diabetes mellitus patients.
Improvement in glycemic control in type 2 diabetes mellitus patients by use of a pen injector.

ADRENALIN [Epinephrine^{C₉H₁₃NO₃}]

eq 1mg base/ml (eq 1mg base/ml) (intramuscular, intraocular, subcutaneous injectable)

eq 30mg base/30ml (eq 1mg base/ml) (intramuscular, subcutaneous injectable)

Par Sterile Products^{Dec 7, 2012}

Emergency treatment of allergic reactions (type i), including anaphylaxis.

ADVAIR DISKUS 100/50 [Fluticasone Propionate^{C₂₅H₃₁F₃O₅S} : Salmeterol Xinafoate^{C₂₅H₃₇NO₄C₁₁H₈O₃}]

0.1mg/inh : eq 0.05mg base/inh (inhalation powder)

Glaxo Grp Ltd^{Aug 24, 2000}

ADVAIR DISKUS 250/50 [Fluticasone Propionate^{C₂₅H₃₁F₃O₅S} : Salmeterol Xinafoate^{C₂₅H₃₇NO₄C₁₁H₈O₃}]

0.25mg/inh : eq 0.05mg base/inh (inhalation powder)

Glaxo Grp Ltd^{Aug 24, 2000}

ADVAIR DISKUS 500/50 [Fluticasone Propionate^{C₂₅H₃₁F₃O₅S} : Salmeterol Xinafoate^{C₂₅H₃₇NO₄C₁₁H₈O₃}]

0.5mg/inh : eq 0.05mg base/inh (inhalation powder)

Glaxo Grp Ltd^{Aug 24, 2000}

ADVAIR HFA [Fluticasone Propionate^{C₂₅H₃₁F₃O₅S} : Salmeterol Xinafoate^{C₂₅H₃₇NO₄C₁₁H₈O₃}]

0.045mg/inh : eq 0.021mg base/inh (inhalation aerosol, metered)

0.115mg/inh : eq 0.021mg base/inh (inhalation aerosol, metered)

0.23mg/inh : eq 0.021mg base/inh (inhalation aerosol, metered)

Glaxo Grp Ltd^{Jun 8, 2006}

ADVIL [Ibuprofen^{C₁₃H₁₈O₂}]

OTC

200mg (oral tablet)

Pfizer^{May 18, 1984}

ADVIL LIQUI-GELS [Ibuprofen^{C₁₃H₁₈O₂}]

OTC

eq 200mg free acid and potassium salt (oral capsule)

Pfizer^{Apr 20, 1995}

ADVIL MIGRAINE LIQUI-GELS [Ibuprofen^{C₁₃H₁₈O₂}]

OTC

eq 200mg free acid and potassium salt (oral capsule)

Pfizer^{Mar 16, 2000}

ADZENYS XR-ODT [Amphetamine^C₉H₁₃N]

eq 12.5mg base (oral tablet, orally disintegrating, extended release)

eq 15.7mg base (oral tablet, orally disintegrating, extended release)

eq 18.8mg base (oral tablet, orally disintegrating, extended release)

eq 3.1mg base (oral tablet, orally disintegrating, extended release)

eq 6.3mg base (oral tablet, orally disintegrating, extended release)

eq 9.4mg base (oral tablet, orally disintegrating, extended release)

Neos Theraps^{Jan 27, 2016}

AFEDITAB CR [Nifedipine^{C₁₇H₁₈N₂O₆}]

30mg (oral tablet, extended release)

60mg (oral tablet, extended release)

Watson Labs Teva^{Mar 10, 2000}

AFINITOR [Everolimus^{C₅₃H₈₃NO₁₄}]

10mg (oral tablet)

2.5mg (oral tablet)

7.5mg (oral tablet)

Novartis^{Mar 30, 2009}

Treatment of advanced hormone receptor positive, her2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
Treatment of patients with progessive neuroendocrine tumors of pancreatic origin (pnet) that are unresectable, locally advanced or metastatic.
Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..
Treatment of solid excretory system tumors; advanced renal cell carcinoma (rcc), after failure of treatment with sunitinib or sorafenib.

AFINITOR DISPERZ [Everolimus^{C₅₃H₈₃NO₁₄}]

2mg (oral tablet, for suspension)

3mg (oral tablet, for suspension)

5mg (oral tablet, for suspension)

Novartis Pharm^{Aug 29, 2012}

Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..

AFREZZA [Insulin Recombinant Human]

12 units/inh (inhalation powder)

4 units/inh (inhalation powder)

8 units/inh (inhalation powder)

Mannkind^{Apr 17, 2015}

Administration of a composition comprising insulin complexed with a diketopiperazine..
Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
Administration of fdkp microparticles comprising insulin..
Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
Pulmonary administration of a composition comprising insulin bound to a complexing agent..
Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
Use of an inhaler to administer dry powder medicament.

AGGRENOX [Aspirin^C₉H₈O₄ : Dipyridamole^{C₂₄H₄₀N₈O₄}]

25mg : 200mg (oral capsule, extended release)

Boehringer Ingelheim^{Nov 22, 1999}

To reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

AIRDUO RESPICLICK [Fluticasone Propionate^{C₂₅H₃₁F₃O₅S} : Salmeterol Xinafoate^{C₂₅H₃₇NO₄C₁₁H₈O₃}]

0.055mg/inh : eq 0.014mg base/inh (inhalation powder)

0.113mg/inh : eq 0.014mg base/inh (inhalation powder)

0.232mg/inh : eq 0.014mg base/inh (inhalation powder)

Teva Pharm^{Jan 27, 2017}

Treatment of asthma.

AKNE-MYCIN [Erythromycin^{C₃₇H₆₇NO₁₃}]

2% (topical ointment)

Dow Pharm^{Jan 10, 1985}

AKTEN [Lidocaine Hydrochloride^{C₁₄H₂₂N₂OClHH₂O}]

3.5% (ophthalmic gel)

Akorn^{Oct 7, 2008}

Method of inducing topical anesthesia in the eye.

AKTIPAK [Benzoyl Peroxide^{C₁₄H₁₀O₄} : Erythromycin^{C₃₇H₆₇NO₁₃}]

5% : 3% (topical gel)

Cutanea^{Nov 27, 2000}

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for X

TOE NAIL FUNGUS [onychomycosis]
Mix equal parts brown x'>Listerine antiseptic mouth wash and white vinegar. Soak feet in solution for 30 minutes daily until infection is cured.OscarWilde | November 4th, 2017

SORE THROAT
Mix 6 pressed garlic cloves with warm water. Gargle twice daily. Continue for 3 days.OscarWilde | November 4th, 2017

FOOT ODOR
Mix 1 part vinegar with 2 parts water. Soak feet daily to eliminate bacteria.
Or, soak feet in strong black tea for 30 minutes daily.IvanTurgenev | November 4th, 2017

CANNOT SLEEP OR JET LAG [insomnia]
Eat a small bowl of tart cherries (not the sweet variety) or before bedtime. Or, drink a glass of XRPmh'>tart cherry juice. Warm baths can also relax your body. | November 5th, 2017

PUFFY EYES
Tip a xCi'>black tea bag into hot water for a minute or two, then cool in the refrigerator or freezer. Apply damp tea bags over closed eyes for approximately 10 minutes.Nobody | November 5th, 2017

PREVENT HANGOVER
Before going to bed, take a B-50 Complex supplement. Drink lots of water.
Mechanism - B vitamins help break down alcoholThomasitase | November 5th, 2017

PREVENT VOMITING
Apply a small amount of isopropyl alcohol to a dry cotton ball or pad. Hold it up to your nose and take a few breaths. Limit to a maximum of 3 breaths ever 10 minutes.
Mechanism - isopropyl alcoholJw | November 5th, 2017

HEARTBURN [gastroesophageal reflux disease]
Eat a high-fiber diet that include beans.
Mechanism - Fiber helps move food out of the stomach faster reducing reflux.RudyardKipling | November 5th, 2017

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

X

X FDA Approved Drugs

Home Remedies for X